Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

Xingyong Wan1, Chengfu Xu1, Chaohui Yu1, Youming Li1
1Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

Tóm tắt

Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public health problem worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD that may progress to cirrhosis and hepatocellular carcinoma. The pathogenesis of disease progression from NAFLD to NASH has not been fully understood. Immunological mechanisms that have been increasingly recognized in the disease progression include defects in innate immunity, adaptive immunity, Toll-like receptor (TLR) signaling, and gut-liver axis. The NLRP3 inflammasome is an intracellular multiprotein complex involved in the production of mature interleukin 1-beta (IL-1β) and induces metabolic inflammation. NLRP3 inflammasome has been recently demonstrated to play a crucial role in the progression of NASH. This review highlights the recent findings linking NLRP3 inflammasome to the progression of NASH.

Từ khóa


Tài liệu tham khảo

10.1111/j.1572-0241.2003.07486.x

10.1146/annurev-pathol-121808-102132

10.1002/hep.24001

10.1016/j.cld.2012.05.003

10.1016/s0016-5085(98)70599-2

10.1053/bega.2002.0333

10.1053/gast.2001.23256

10.1016/j.jhep.2012.03.035

10.1155/2013/678627

10.1038/nature10759

10.1002/hep.24341

10.1002/hep.25932

10.1007/s00109-014-1170-1

10.1074/jbc.M412220200

10.1002/hep.23167

10.1016/j.jhep.2010.03.016

10.1053/j.gastro.2010.03.052

10.1016/j.jhep.2011.01.048

10.1073/pnas.1100255108

10.1038/nm.2279

10.1038/labinvest.2012.45

10.1016/j.jhep.2011.10.005

10.1371/journal.pone.0056100

10.1111/liv.12570

10.1002/hep.23719

10.1016/j.jhep.2011.05.019

10.3390/ijms15058591

10.1038/nrgastro.2013.149

10.1002/hep.21763

10.1042/cs20030326

10.1194/jlr.p055640

10.1371/journal.pone.0107658

10.1002/hep.23535

10.1016/j.jhep.2007.06.020

10.1016/j.jhep.2008.02.011

10.1002/hep.25789

10.1002/hep.22941

10.1194/jlr.m053785

10.1194/jlr.M034876

10.1002/hep.24283

10.1038/ng.257

10.1074/jbc.m112.417014

10.1136/gutjnl-2011-301857

10.1002/hep.23599

10.1002/hep.26937

10.1002/hep.26749

10.1038/labinvest.2012.176

10.1111/jgh.12019

10.1007/s12072-013-9468-6

10.1002/hep.26081

10.1007/s00125-010-1747-3

10.1097/01.alc.0000189287.83544.33

10.1186/1471-230x-10-52

10.1002/hep.24552

10.1016/j.jhep.2007.04.019

10.1136/gutjnl-2011-300269

10.1111/1440-1681.12241

10.1089/met.2013.0120

10.1111/liv.12537

10.1159/000324281

10.2174/1381612811319290011

10.1155/2010/362847

10.1111/j.1478-3231.2008.01723.x

10.1002/hep.22711

10.1186/1472-6882-11-53

10.1016/j.dld.2014.01.156

10.1111/bph.12226

10.1038/ni.2022

10.1038/nature10809

10.1002/hep.24747